Jump to content

Yttrium (90Y) tacatuzumab tetraxetan

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Anypodetos (talk | contribs) at 11:04, 7 October 2009 (Partly sourced). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)

Yttrium (90Y) tacatuzumab tetraxetan
Monoclonal antibody
Type	?
Source	Human
Target	α-fetoprotein
Clinical data
ATC code	none
Identifiers
CAS Number	476413-07-7
Chemical and physical data
Formula	C₆₄₇₀H₉₉₇₁N₁₇₁₂O₂₀₀₇S₄₂⁹⁰Y
Molar mass	145 kDa

Tacatuzumab tetraxetan is a humanized monoclonal antibody used to treat cancer.^{[citation needed]} Tacatuzumab it attached to a chelator, tetraxetan, which binds a radioisotope, yttrium-90.^[1]

References

^ WHO Drug Information

Template:Humanizedmonoclonals

This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Yttrium_(90Y)_tacatuzumab_tetraxetan&oldid=318431139"